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ABSTRACT
Objective This is a prospective population screening 
study for autism in toddlers aged 18–30 months old using 
the Quantitative Checklist for Autism in Toddlers (Q- CHAT), 
with follow- up at age 4.
Design Observational study.
Setting Luton, Bedfordshire and Cambridgeshire in the 
UK.
Participants 13 070 toddlers registered on the Child 
Health Surveillance Database between March 2008 and 
April 2009, with follow- up at age 4; 3770 (29%) were 
screened for autism at 18–30 months using the Q- CHAT 
and the Childhood Autism Spectrum Test (CAST) at follow- 
up at age 4.
Interventions A stratified sample across the Q- CHAT 
score distribution was invited for diagnostic assessment 
(phase 1). The 4- year follow- up included the CAST and the 
Checklist for Referral (CFR). All with CAST ≥15, phase 1 
diagnostic assessment or with developmental concerns on 
the CFR were invited for diagnostic assessment (phase 2). 
Standardised diagnostic assessment at both time- points was 
conducted to establish the test accuracy of the Q- CHAT.
Main outcome measures Consensus diagnostic 
outcome at phase 1 and phase 2.
Results At phase 1, 3770 Q- CHATs were returned (29% 
response) and 121 undertook diagnostic assessment, 
of whom 11 met the criteria for autism. All 11 screened 
positive on the Q- CHAT. The positive predictive value (PPV) 
at a cut- point of 39 was 17% (95% CI 8% to 31%). At 
phase 2, 2005 of 3472 CASTs and CFRs were returned 
(58% response). 159 underwent diagnostic assessment, 
including 82 assessed in phase 1. All children meeting the 
criteria for autism identified via the Q- CHAT at phase 1 
also met the criteria at phase 2. The PPV was 28% (95% CI 
15% to 46%) after phase 1 and phase 2.
Conclusions The Q- CHAT can be used at 18–30 months 
to identify autism and enable accelerated referral for 
diagnostic assessment. The low PPV suggests that for every 
true positive there would, however, be ~4–5 false positives. 
At follow- up, new cases were identified, illustrating the 
need for continued surveillance and rescreening at multiple 
time- points using developmentally sensitive instruments. 
Not all children who later receive a diagnosis of autism are 
detectable during the toddler period.
INTRODUCTION
Autism affects approximately 1%–2% of the 
population.1 2 Screening requires a stand-
ardised and systematic approach to iden-
tify children who may require a diagnostic 
assessment. The costs and benefits of autism 
population screening need to be carefully 
balanced. Undue anxiety in false positives 
and the need for sufficient support services 
for those diagnosed should be offset by the 
many benefits of accurate screening that 
include earlier diagnosis, more timely access 
to specific interventions3 and better support 
for parents. In the UK, no autism- specific 
screening instrument is recommended by the 
National Institute for Health and Care Excel-
lence.4 Autism is variable in onset and signif-
icance over time of specific symptoms. No 
existing screening instrument, used at a single 
time- point, reaches a minimum of 80% sensi-
tivity and specificity.5 In contrast, the Amer-
ican Academy of Pediatrics6 recommends 
routine screening at well- child checks using 
What is known about the subject?
 ► In the UK, a systematic population screening pro-
gramme for autism is not recommended to facilitate 
early detection. This is because general population 
screening tests that have been evaluated using sys-
tematic follow- up have not proved accurate.
What this study adds?
 ► It is possible to detect autism at 18–30 months.
 ► It is not possible to identify every child at a very 
young age who will later be diagnosed with autism.
 ► The Quantitative Checklist for Autism in Toddlers can 
be used to screen toddlers at 18–30 months.
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the Checklist for Autism in Toddlers (CHAT)7 8 and the 
Modified Checklist for Autism in Toddlers (M- CHAT),9 
despite the limited research evidence for their use10 and 
insufficient evidence to determine if certain risk factors 
modify the performance characteristics of the tests.11
Lengthy delays between the first concerns and an even-
tual diagnosis are often experienced.12 There has been 
no evidence of a reduction in the age at diagnosis over 
the past decade in the UK.13 Beliefs held by health profes-
sionals about screening for autism (eg, system capacity, 
interventions available) may influence practice.14 Equally, 
young children with autism may not present salient atyp-
ical behaviour in a short consultation to warrant an assess-
ment referral. Atypical behaviours, such as restricted and 
repetitive behaviours, extend to the neurotypical child on 
a continuum15 and may reduce with time.16 The reduc-
tion of inappropriate referrals to already overstretched 
services could serve to benefit children, their families 
and health services. Of the referrals to a child develop-
ment centre in the UK for possible autism, 60% resulted 
in an autism diagnosis. It is unclear what the outcome was 
for the remainder of the referrals.17
The CHAT7 is a short parent report questionnaire 
combined with a health professional observation. The 
CHAT was tested prospectively in 18- month- old toddlers 
from the general population, with a diagnostic follow- up 
of those who scored above the cut- point to allow esti-
mation of both sensitivity and specificity. At 18 months 
the CHAT identified 92% of children with autism when 
assessed and diagnosed by two independent psychiatrists 
using the Diagnostic and Statistical Manual of Mental 
Disorders, Third Edition, Revised criteria as the gold 
standard at that time.8 By 6- year follow- up, the sensitivity 
was 38%, indicating that many children did not present 
with sufficient features of autism to meet the diagnostic 
criteria at 18 months. Nevertheless, the CHAT had very 
high specificity (98%) and was the first demonstration 
internationally that autism could be diagnosed as early as 
18 months of age, when previously age at first diagnosis 
was typically not until later in childhood.18 The CHAT was 
based on toddler developmental precursors of ‘theory of 
mind’,19 such as joint attention20–22 and pretend play,23 
and so stemmed from a cognitive developmental theory 
about the nature of autism.24
The M- CHAT9 is a 23- item parent report questionnaire 
used in the US healthcare system. It incorporates the 
original nine items from the CHAT and includes addi-
tional items that may be characteristic of a young child 
with autism. Initial results reported a sensitivity of 0.97, a 
specificity of 0.99 and a positive predictive value (PPV) of 
0.68 when used with a telephone follow- up. Despite limita-
tions to the initial studies25 (eg, referred and unselected 
samples were combined and no systematic follow- up), the 
M- CHAT has been examined in a large population sample 
at 18 months.26 Specificity was high (0.93), but sensitivity 
was low (0.34) and PPV was 0.35. The authors concluded 
that it may not be possible to identify all children with 
autism at 18 months. The M- CHAT has subsequently 
been revised (M- CHAT, Revised with Follow- Up),27 
consisting of 20 items and including examples to provide 
developmental context and clarity. This was tested in 
a large population (n=16 071), finding PPV to be 0.48, 
while another study28 reported PPV to be 0.54. Sensitivity 
could not be determined in these two studies because 
only the screen positives were followed up. An additional 
study examined the accuracy of the Modified Checklist 
for Autism in Toddlers with Follow- Up (M- CHAT/F) in 
a universal, primary care- based screening context that 
involved systematic follow- up up to 8 years.29 Diagnoses 
were ascertained independent of the screen. The study 
reported sensitivity of 38.8% and PPV of 14.6%, with 
almost universal screening being achieved (91%) by 
incorporating autism screening into routine check- ups 
and integrating these within the electronic health record.
The Quantitative Checklist for Autism in Toddlers 
(Q- CHAT)30 was developed to dimensionalise autism 
in toddlerhood. It has been demonstrated that autistic 
traits can be measured quantitatively in the general 
population, using the Autism Spectrum Quotient (AQ) 
in adulthood,31 the AQ- Adolescent,32 the AQ- Child33 
and the Social Responsiveness Scale,34 in older children 
and adults. The Q- CHAT is a parent report 25- item ques-
tionnaire that includes the CHAT and additional items. 
Each item is converted to a rating scale, thus quantifying 
autistic traits. This allows for the possibility of reporting 
behaviour at a reduced frequency. For example, the 
response options on the item concerning protodeclara-
tive pointing range from many times a day (least autistic 
response) through to never (most autistic response). The 
Q- CHAT domains include social communication, repet-
itive, stereotyped and sensory behaviours. A preliminary 
study examined the distribution of the Q- CHAT in an 
unselected sample of toddlers aged 18–24 months old and 
in a sample of children already diagnosed on the autism 
spectrum. Results indicated that the Q- CHAT discrimi-
nated well between young children with autism and unse-
lected toddlers in the population at 18–24 months.30 The 
Q- CHAT was not evaluated as a prospective screen in this 
sample. The Q- CHAT has been translated and validated 
in other countries, including Italy and Chile.35 36 A short 
version of the Q- CHAT (Q- CHAT-10)37 was developed 
and tested retrospectively on toddlers with an autism 
diagnosis compared with toddlers from the unselected 
population reported. The sensitivity and specificity were 
0.91 and 0.89, respectively. However, these studies were 
not longitudinal and so they cannot address the question 
of whether it is best to screen for autism at a single or 
multiple time- points. See Petrocchi et al38 for a recent 
systematic review outlining the psychometric properties 
of autism- specific screening instruments.
The objective of this study is to report a population 
screening study of nearly 4000 toddlers at 18–30 months 
using the Q- CHAT, with diagnostic assessments on a 
subsample of responders and subsequent follow- up at 
4 years. The Child Health Surveillance Database was used 
to identify the population eligible to screen with the 
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Q- CHAT. The study is reported in two phases, as under-
taken. The aims of phase 1 were (1) to determine the test 
accuracy of the Q- CHAT in the toddler period and (2) to 
determine an optimal screening cut- point that could be 
used to select toddlers for a diagnostic assessment. The 
aims of phase 2 were (1) to rescreen the population at 
a minimum age of 4 using the Childhood Autism Spec-
trum Test (CAST)39 in order to identify children with 
autism who were not identified at phase 1 (false nega-
tives) and the Checklist for Referral (CFR) to seek infor-
mation on the child’s history of developmental concerns; 
(2) to confirm the outcome of those who were identified 
by the Q- CHAT at 18–30 months, and those who were 
not, by conducting diagnostic assessments; (3) to assess 
the stability of the diagnostic outcome from phase 1 to 
phase 2; and (4) to assess the discriminant power of the 
Q- CHAT and CAST and CFR in distinguishing autism 
cases from non- autism cases. This two- phase design 
allowed us to report sensitivity, specificity and PPV. Test 
accuracy at phase 1 was not evaluated at the time to 
ensure researchers remained blind to the results when 
undertaking phase 2.
METHODS
Patient and public involvement
The first and senior authors (CA and SB- C) gave talks to 
parent support groups and clinicians about this research 
during all phases of the research and received feedback 
through questions and discussion. The format of the 
Q- CHAT itself was co- designed with a parent support 
group.
Setting, study design and procedure
Phase 1
All caregivers of infants between the ages of 18 and 30 
months who were registered on the Child Health Surveil-
lance Database at the three primary care trusts (PCT) 
on the date of mailing were invited to complete the 
Q- CHAT between March 2008 and April 2009. Question-
naires were sent in three batches to manage capacity of 
the team. Screening was conducted via a postal question-
naire, distributed by the PCT. Luton questionnaires were 
mailed in March 2008, Bedfordshire questionnaires were 
mailed in May 2008, and Cambridgeshire questionnaires 
were mailed in April 2009. Questionnaires were posted 
twice, 2 weeks apart, to maximise response. Returned 
questionnaires were scored by the research team and 
the sampling strategy, as detailed in the next section, was 
applied to establish the diagnostic assessment sample. 
Research diagnostic assessments were arranged as soon 
as possible after completion of the Q- CHAT. All members 
of the diagnostic assessment team remained blind to 
the child’s Q- CHAT score. The Q- CHAT was completed 
a second time prior to any of the diagnostic assessment 
battery in order to later examine the test–retest reliability 
of the Q- CHAT in a sample enriched with high scorers, 
which will be reported separately. Diagnostic outcome 
was defined by the researchers reaching a consensus diag-
nosis using all diagnostic assessment data and researcher 
judgement.
Phase 1 sampling strategy
The strategy for selecting participants for follow- up diag-
nostic assessment was weighted towards those with higher 
scores. The rationale for choosing 44 as the cut- point 
for inviting participants for follow- up diagnostic assess-
ment at phase 1 was based on anticipated estimates of 
the prevalence of autism (approximately 1%) balanced 
with the knowledge that over 70% of children who 
already had a diagnosis on the autism spectrum scored 
44 and above in our initial study.30 A cut- point of 44 was 
therefore chosen in order to maximise sensitivity while 
generating a feasible number of diagnostic assessments 
to be completed. In contrast, the strategy for identifying 
the optimal screening cut- point on the Q- CHAT was not 
determined until after phase 2 diagnostic assessments 
were complete, which was one of the aims of the study. 
At a cut- point of 44 on the Q- CHAT at phase 1, 100% 
of children were selected for diagnostic assessment. To 
ensure that children with missing data were not missed 
from being included in a high scoring group (44+), 
missing Q- CHAT items were allocated the maximum 
item score (4) and the total Q- CHAT score recalculated. 
The rationale for incorporating missing data into the 
sampling strategy was to ensure that children with a high 
likelihood of having many autistic traits (and therefore 
potentially being autistic) but who had sufficient missing 
data to put them in a sampling band where the chance 
of being selected was low were included in the follow- up 
diagnostic assessments. Each Q- CHAT questionnaire 
therefore had two scores: the observed (assuming each 
item of missing data would score as not impaired) and 
the maximum (assuming each item of missing data would 
score as impaired). Observed and maximum Q- CHAT 
scores were grouped into four bands (≥44, 41–43, 38–40, 
≤37). This ensured that missing data meant a child was 
more likely to be assessed.
The final sampling groups were determined according 
to the maximum score, taking into account the move-
ment across score groups from observed score to 
maximum score. For example, if a child’s observed score 
was 40 and there were two missing Q- CHAT items, 8 was 
added to the observed score to give a score of 48, which 
would therefore be that child’s sampling score. Sampling 
group allocation and randomisation took place prior to 
establishing whether or not the family had consented for 
further contact.
When the chance of being selected was less than 100%, 
selection for diagnostic assessment was undertaken using 
a random number generator ( www. random. org). One 
per cent of the children who had a maximum score ≤37 
were selected for diagnostic assessment to ensure that the 
diagnostic assessment team were blind to whether there 
were likely to be concerns about the child at the time of 
diagnostic assessment.
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Phase 2
All caregivers who consented to further contact 
following the phase 1 screening (n=3472) were invited 
to participate in phase 2 at a minimum age of 48 
months, between January and July 2011. Caregivers 
were sent the CAST, a 37- item tool to detect autism 
in children among those aged 4–11 years, in a non- 
clinical setting.39 40 Parents were also sent a brief check-
list enquiring about whether the child had ever been 
referred or diagnosed with any developmental and/or 
medical condition (CFR).
Phase 2 sampling
All children who scored ≥15 on the CAST (the 
recommended screening cut- point for epidemiolog-
ical research)33 were invited for a phase 2 diagnostic 
assessment, along with all children whose caregiver 
indicated on the CFR that they had been referred for 
any of the following reasons: language delay/disorder, 
attention deficit hyperactivity disorder/attention 
deficit disorder, dyspraxia, autism spectrum condition 
(autism), genetic/chromosomal abnormality, epilepsy, 
Tourette syndrome and tuberous sclerosis. There was 
also a space on the CFR for the caregiver to provide 
more information about the reason for the referral and 
whether any diagnosis had been made. If the caregiver 
indicated that their child had been referred for any 
other reason not specified on the CFR, the research 
team decided on a case- by- case basis whether or not to 
invite the family for diagnostic assessment. All children 
who participated in phase 1 diagnostic assessments 
were invited for a phase 2 diagnostic assessment in 
order to assess the stability of the diagnostic outcome 
from phase 1 to phase 2.
Diagnostic outcome
In both phase 1 and phase 2, diagnostic outcome 
was defined by the researchers reaching a consensus 
diagnosis using all diagnostic assessment data and 
researcher judgement as possible autism or autism 
spectrum (if they met the International Statistical 
Classification of Diseases 10th Edition criteria41 for a 
pervasive developmental disorders diagnosis), atypical 
(if the child showed developmental concerns that were 
not related to autism) or typical (if there were no devel-
opmental concerns about the child). We used the term 
‘possible’ to reflect the reluctance of some clinicians to 
commit to an autism diagnostic label at such an early 
age. It was not possible for all of the diagnostic assess-
ment team to remain blind to the diagnostic outcome 
from the phase 1 diagnostic assessments at phase 2. 
However, the diagnostic assessment team re- examined 
blind to the Q- CHAT score throughout phase 2 diag-
nostic assessments.
The University of Cambridge was the sponsor of this 
research. Informed consent was obtained from all care-
givers included in the study.
Measures
Quantitative Checklist for Autism in Toddlers
The Q- CHAT has a forced choice design, with five possible 
responses for each item (with the exception of item 4, 
see below). For each item, the response representing the 
most ‘autistic’ symptomatology scores 4 points and the 
least ‘autistic’ response scores 0. On approximately half 
the items (items 3, 7, 8, 11, 12, 13, 16, 18, 20, 22, 23, 
24, 25) the ‘autistic’ response is the positive one. On the 
other half (items 1, 2, 4, 5, 6, 9, 10, 14, 15, 17, 19, 21) the 
‘autistic’ response is the negative one. Item 4 is concerned 
with speech and includes a sixth option, ‘my child does 
not speak’, also scoring 4 points. The total Q- CHAT score 
is obtained by summing the score on each item, giving a 
maximum of 100. Each of the 25 questions is accompa-
nied by a colour illustration to attempt to increase both 
response and comprehensibility of the items.
Demographic data
Data collected about the child included age, sex, birth 
order, ethnicity and multiple birth status. Data collected 
about the caregivers included socioeconomic status (SES) 
and parental educational attainment. SES was derived at 
person level rather than household level, using the five 
class system of the National Statistics Socio- economic Clas-
sification.42 Parental educational attainment was assessed 
by the highest level of qualification of each parent.
Diagnostic assessment
The Autism Diagnostic Observation Schedule- Generic 
(ADOS- G)43 was completed. The ADOS- G is a semis-
tructured, standardised assessment of social interaction, 
communication, play and imagination. It is a reliable and 
valid measure for the diagnosis of autism relative to those 
with non- autistic conditions. Module 1 was chosen at phase 
1 since it was not expected that many children would have 
expressive language abilities beyond basic phrase speech. 
Module 2 or 3 was chosen at phase 2. ADOS- G assessments 
were videotaped, but item scoring was conducted inde-
pendently by two members of the diagnostic assessment 
team and consensus codes were agreed as soon as possible 
after the diagnostic assessment. The diagnostic assessment 
team comprised at least one very experienced research 
psychologist, alongside a research assistant who also had 
been trained to reliability standards.
The Autism Diagnostic Interview- Revised (ADI- R)44 
was completed with the caregiver. The ADI- R is a diag-
nostic semistructured interview that generates an algo-
rithm score based on behaviours in three domains: social 
communication, social interaction and repetitive and 
stereotyped behaviours and interests. The interview also 
enquires about age of onset of symptoms. Due to the 
practicalities in arranging the diagnostic assessments, it 
was not possible to counterbalance completion of the 
ADOS- G and ADI- R. However, the ADI- R and ADOS- G 
were never carried out by the same researcher to reduce 
the possibility of experimenter expectation bias. All 
ADI- R assessments were audio- taped.
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The Mullen Scales of Early Learning (MSEL)45 is a 
standardised measure of cognitive, expressive and recep-
tive language, motor and perceptual abilities. The MSEL 
was usually carried out while the other researcher was 
completing the ADI- R with the caregiver. The gross motor 
scale was not completed as this does not contribute to the 
overall early learning composite.
The Vineland Adaptive Behavior Scale (VABS)46 is a stan-
dardised measure of personal and social skills. The inter-
view version was completed with the parent. There are 
four domains that measure communication, daily living 
skills, socialisation and motor skills, as well as an optional 
maladaptive domain (not completed here). The VABS was 
usually completed at the end of the testing session.
Statistical methods
Due to the stratified sample all analyses were adjusted for 
the probability of being selected into the diagnostic assess-
ment subsample at each phase via inverse probability 
weighting. This takes account of the differences in sampling 
proportions and the selective participation in the diagnostic 
assessment across the sampling groups. A sensitivity analysis 
was undertaken that also included the non- response rates 
at each health trust within the weights. A receiver operating 
characteristic (ROC) area under the curve analysis assessed 
the discriminant power of the Q- CHAT and CAST and 
CFR in distinguishing autism cases from non- autism cases 
(defined as typical and atypical) and from autism and all 
other atypical development from typically developing chil-
dren, across all score values. CIs were obtained from robust 
SEs. All analyses were undertaken in Stata V.14.47 A series 
of sensitivity analyses to decisions on the screening instru-
ment were undertaken (see table 2). At both phases, these 
included examining cut- points at 31 and 38, as well as a cut- 
point at 39, including those parents who reported concerns, 
and 39 adjusted for initial non- response at screening.
RESULTS
Phase 1
There were 3770 Q- CHAT questionnaires returned: 436 
(14% response) from Luton, 1256 (25% response) from 
Bedfordshire and 2078 (42% response) from Cambridge-
shire. Of these 223 were selected for diagnostic assess-
ment, 32 did not give consent to be contacted and there-
fore 191 were invited and 121 completed the diagnostic 
assessments. See table 1 for phase 1 sampling strategy 
with study numbers, online supplemental figure 1 for 
the flow chart from phase 1, and online supplemental 
table 1 for the characteristics of children and their fami-
lies throughout the study; online supplemental figure 
2 shows the distribution of the Q- CHAT with sampling 
bands indicated.
Following diagnostic assessment, 11 children were 
defined as possible autism, 16 as atypical (7 language 
delay, 5 developmental delay, 4 other atypical) and 94 as 
typical. At a cut- point of ≥39, the PPV for autism was 17% 
(95% CI 8% to 31%) (table 2).
Phase 2
From phase 1 caregivers, 3472 consenting caregivers 
were sent the phase 2 study materials, and 2005 returned 
both the CFR and the CAST (58% response), a further 
6 returned only the CAST, and 5 returned only the CFR. 
Forty- two children who had a diagnostic assessment in 
phase 1 did not return the CAST or the CFR.
In phase 2, 172 caregivers reported developmental 
concerns on the CFR and 43 children scored 15 and 
above on the CAST (not in phase 1 diagnostic assessment 
sample) and were selected for diagnostic assessment. 
Eighty- one children who had been assessed in phase 1 
completed the diagnostic assessment (1 child did not 
complete all the diagnostic assessments and was there-
fore not included in the analysis). In total, 158 children 
completed the diagnostic assessment at phase 2, 23 with 
CFR concerns and CAST score ≥15, 63 with CFR concerns 
and CAST scores ≤15, 6 with CAST scores ≥15 with no 
CFR concerns, 56 who scored ≤15 on the CAST and who 
did not report any developmental concerns on the CFR 
but who were assessed in phase 1, and 10 children who 
were assessed in phase 1 but who did not return the CFR 
or CAST. Figure 1 summarises the overall study design, 
with figure 2 showing the characteristics and comparison 





(missing items=4) % sampled Total
Assessment numbers
Selected Invited Agreed
1 ≥38 ≥44 100 86 86 74 40
2 ≤37 ≥44 50 21 10 9 6
3 41–43 41–43 50 61 31 28 16
4 ≤40 41–43 50 21 10 8 5
5 38–40 38–40 25 129 31 28 20
6 ≤37 38–40 25 25 5 5 2
7 ≤37 ≤37 1 3300 40 39 32
Total 3643 213 191 121
Q- CHAT, Quantitative Checklist for Autism in Toddlers.
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of the Q- CHAT at phases 1 and 2 and the CAST at phase 2 
(not weighted). Eleven children were defined as possible 
autism in phase 1 (prevalence of 0.98%, 95% CI 0.45% 
to 2.16%).
Eighty- one children were assessed at both phase 1 and 
phase 2. Of the nine children whose diagnostic outcome 
at phase 1 was possible autism and who had a diagnostic 
assessment in phase 2, all were still classified with autism. A 
further six children were now classified with autism (four 
who were typical at phase 1 and two who were atypical). 
Seventy- seven children were assessed for the first time at 
phase 2, having completed the Q- CHAT at phase 1. Some 
of these children were invited for diagnostic assessment due 
to indicating on the CFR that they had received a clinical 
diagnosis of autism and others because of their CAST score 
(15 or above). Of these 29 were classified as autism, 24 as 
atypical development and 24 as typically developing, giving 
a prevalence of autism of 1.57% (95% CI 0.90% to 2.74%). 
Figure 3 shows participants’ study flow through screening 
and diagnostic assessments from phase 1 to phase 2. Clin-
ical characterisation of the sample by screening status will 
be reported in a separate paper.
Using the CAST alone as the screen at phase 2, 1994 chil-
dren had complete data. At a cut- point of ≥15, the sensitivity 
was 56% (95% CI 37% to 74%), specificity was 100% (95% 
CI 99% to 100%) and PPV was 81% (95% CI 59% to 92%) 
(table 2). The area under the ROC curve was 0.94 (95% CI 
0.88 to 0.99) (online supplemental figure 3). Adding in the 
CFR selection criteria improved sensitivity to 88% (95% CI 
63% to 97%), but decreased specificity slightly to 97% (95% 
CI 95% to 98%), with a PPV of 34% (95% CI 23% to 46%) 
and an area under the ROC curve of 0.99 (95% CI 0.98 to 
1.00). Online supplemental figure 4 shows a box plot of the 
distribution of Q- CHAT scores split by both phase 1 and 
phase 2 diagnosis.
At a cut- point of ≥39, the sensitivity of the Q- CHAT in 
predicting phase 2 outcome (autism vs atypical and/or 
typical) was 44% (95% CI 26% to 64%), specificity was 
98% (95% CI 97% to 99%) and PPV was 28% (95% CI 
15% to 46%) (table 2). The area under the ROC curve 
was 0.86 (95% CI 0.78 to 0.94). The cut- point of 39 was 
determined by the data obtained at phase 1 and phase 
2. We selected participants across the threshold of 44 
following the Q- CHAT at phase 1 in varying proportions 
Figure 1 Study design. CAST, Childhood Autism Spectrum 
Test; CFR, Checklist for Referral; Q- CHAT, Quantitative 
Checklist for Autism in Toddlers.
Figure 2 Characteristics and comparison of the Q- CHAT at phase 1 and phase 2 and the CAST at phase 2 (not weighted). 
CAST, Childhood Autism Spectrum Test; Q- CHAT, Quantitative Checklist for Autism in Toddlers.
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in order to accurately determine where the cut- point 
should lie. Examination of the Q- CHAT data against 
diagnostic outcome suggested that the cut- point of 39 is 
the point that maximises sensitivity and specificity at 18 
to 30 months.
Sensitivity analyses
Optimising the Q- CHAT cut- point for phase 2 outcome 
found two additional cut- points: Q- CHAT 31+ maxim-
ised sensitivity and specificity at the cost of false positives 
and using Q- CHAT 38+ marginally improved sensitivity 
with little additional benefit. Other sensitivity anal-
yses at phase 1 and phase 2 are shown in table 2. See 
figure 2 for the characteristics and comparison of the 
Q- CHAT at phase 1 and phase 2 and the CAST at phase 
2 (not weighted), according to diagnostic outcome.
DISCUSSION
The first two aims of the study were to determine the 
optimal screening cut- point on the Q- CHAT and to 
determine the test accuracy. At phase 1 outcome, all 
children who were classified as possible autism failed the 
Q- CHAT at a cut- point of 39, demonstrating that early 
detection and diagnosis of autism is possible. The PPV 
of the Q- CHAT for autism was 17%. Misinterpretation of 
behaviours that are not well established as well as devel-
opmental immaturity may contribute to low PPV. An aim 
of phase 2 was to rescreen the population at a minimum 
age of 4 using the CAST in order to identify children with 
autism who were not identified at phase 1 (false nega-
tives) and the CFR to seek information on the child’s 
history of developmental concerns and diagnoses. The 
results indicated that the Q- CHAT did not identify all 
children who were later diagnosed with autism by age 4. 
We therefore were able to confirm the outcome of those 
who were identified by the Q- CHAT at 18–30 months 
and those who were not. A further aim in phase 2 was 
to confirm the discriminant power of the Q- CHAT and 
CAST and CFR in distinguishing autism cases from non- 
autism cases. At a cut- point of ≥39, the sensitivity of the 
Q- CHAT in predicting autism was 44% (95% CI 26% to 
64%), specificity was 98% (95% CI 97% to 99%) and PPV 
was 28% (95% CI 15% to 46%). This demonstrates that 
the Q- CHAT alone cannot be used to identify all children 
with autism. This might reflect the Q- CHAT properties, 
but equally it likely reflects a subgroup of children with 
autism who do not show symptoms of sufficient ‘severity’ 
until later in childhood, and/or that symptoms of autism 
change with age, and so require developmentally sensi-
tive instruments at different ages. The Diagnostic and 
Statistical Manual of Mental Disorders-5’s caveat that 
symptoms might not fully manifest until social demands 
exceed capacities may apply here. The CAST picked 
up many of the cases of autism that were missed by the 
Q- CHAT, demonstrating the need for repeat screening 
rather than relying on a single instrument at one time- 
point. However, the sensitivity of the CAST at a cut- point 
of 15 was only moderate (56%), compared with our 
earlier study showing a sensitivity of 100%.39 All children 
who participated in phase 2 diagnostic assessments who 
were identified as ‘possible autism’ at phase 1 were still 
classified as autistic, suggested the stability of the diag-
nosis from phase 1 to phase 2.
A strength of this study was the prospective, 
population- based design which allowed us to assess the 
Q- CHAT accurately at two time- points. Our approach 
to missing data and subsequent sampling strategy 
was conservative and ensured maximum capture of 
potential cases in the diagnostic assessment phase, 
maximising sensitivity. However, studies such as the 
current one are challenged by modest participation 
rates, selection bias and attrition over time. Despite 
adopting strategies to attempt to increase response, 
overall it was low, but not unusual for an unsolicited 
postal survey. Whether or not those who responded 
Figure 3 Participant study flow through screening and 
diagnostic assessments from phase 1 to phase 2. CAST, 
Childhood Autism Spectrum Test; CFR, Checklist for 
Referral; Q- CHAT, Quantitative Checklist for Autism in 
Toddlers.
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initially to the Q- CHAT (which determined the popu-
lation for the rest of the study) were biased towards 
those with concerns (either justified or the ‘worried 
well’) or in the opposite direction remains largely 
unknown. A second limitation is that in phase 1, only 
1% of children who scored ≤37 were sampled. This 
proportion was chosen for pragmatic reasons in rela-
tion to feasibility (ie, to keep the number of lengthy 
diagnostic assessments in children with no develop-
mental concerns to a minimum and to reduce expec-
tation bias in the research team). None of the sampled 
children with scores ≤37 met our diagnostic assessment 
case definition. It is important to underline that these 
results are based purely on outcome at phase 1 and 
do not reflect the overall test accuracy statistics from 
phase 2.
Few studies attempt population screening partly 
because they are very time- consuming and expensive. 
Younger toddlers have mild or transient developmental 
delays that resolve, resulting in low PPV, as was found in 
another study.48 Introducing a follow- up interview (such 
as used with the M- CHAT25 27 28) for those who screen 
positive may reduce the number of unnecessary referrals 
for a diagnostic assessment, especially with children older 
than 20 months.49 Nevertheless, a recent meta- analysis 
of M- CHAT studies found a lack of evidence on its 
performance in low- risk children or at age 18 months.50 
A universal, primary care- based screening study was 
conducted using the M- CHAT/F in the USA. Overall, the 
sensitivity was 38.8% and the PPV was 14.6%. Sensitivity 
was higher in older toddlers and with repeated screen-
ings, whereas PPV was lower in girls.29 This study was the 
first using the M- CHAT to follow up children screened 
in the population, thus allowing for an accurate esti-
mate of the sensitivity of the instrument. Similar results 
were found with another population- based sample (the 
Autism Birth Cohort), whereby the majority diagnosed 
with autism at 6- year follow- up scored below the cut- off 
on the M- CHAT at 18 months.26 Since the publication 
of the original CHAT,7 8 18 no study in the UK to date 
has achieved screening data on such a large population 
sample of toddlers and accurately determined sensitivity 
through follow- up.
Total Q- CHAT score was used to determine which 
sampling band each child fell into. A sum (total) score 
based on equal weighting of all items may not be the 
most appropriate method by which to quantify an indi-
vidual’s autistic traits. Other work by our group has 
shown that there are at least two items on the Q- CHAT 
whereby the prevalence of endorsement of the trait in 
the autistic direction is lower for toddlers with a diagnosis 
of autism, compared with population controls (items 8 
and 18).37 One study51 found specific item clusters which 
gave high sensitivity and specificity values at 18 months 
(100% and 93.9%, respectively). Item response anal-
ysis will be conducted to determine whether every item 
equally contributes useful information about the under-
lying latent dimensions. Defining a threshold on each 
factor that can be measured quantitatively (continuous 
approach) may be a more appropriate scoring method. 
Furthermore, exploration of different age- specific 
scoring algorithms should be implemented to determine 
which variables carry the greatest relative importance to 
optimise screening results.3 49
Overall, this study demonstrates that (1) the Q- CHAT 
identified every child who received an autism diag-
nosis at phase 1 outcome and therefore it is possible 
to detect autism at 18–30 months; and (2) it is not 
possible to identify every child at a very young age 
who will later be diagnosed with autism. The Q- CHAT 
can be used to screen toddlers at 18–30 months for 
autism to enable accelerated referral into the diag-
nostic pathway. However, the PPV is low, thus poten-
tially generating a high number of children who may 
not have autism, but who may still require a develop-
mental assessment to determine whether they warrant 
a referral for intervention and support. Outcome data 
from phase 2 revealed many children with autism that 
the Q- CHAT did not identify. The autism spectrum is 
broad and not every child will be detectable as a young 
toddler. Therefore, when looking at the Q- CHAT 
longitudinally, it is evident that screening at a single 
time- point results in less than optimal test properties. 
In a future study, we will evaluate whether the missed 
cases reflect a subgroup of children with autism whose 
symptoms are not severe enough to warrant a diagnosis 
during toddlerhood and that the symptoms of autism 
change with age. We therefore recommend continued 
surveillance and rescreening at multiple time- points 
using developmentally sensitive instruments in order 
to identify a higher proportion of cases for maximal 
public health impact, which is in line with the recom-
mendation by the American Academy of Pediatrics.52 
This study demonstrates that no single instrument will 
identify all cases of autism at a single time- point. Thus, 
continued monitoring throughout the life course is 
necessary in order to identify when autistic traits begin 
to impair an individual’s life. High- quality evidence 
from random controlled trials is needed to determine 
whether early detection and consequent early imple-
mentation of specific interventions is able to change 
outcomes in toddlers with autism.
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